Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1988 Oct;47(10):838–842. doi: 10.1136/ard.47.10.838

Perivascular infiltration in normal skin of patients with rheumatoid arthritis: association with rheumatoid factors and HLA-DR antigens.

H J Bernelot Moens 1, H J Ament 1, T M Vroom 1, T E Feltkamp 1, J K van der Korst 1
PMCID: PMC1003613  PMID: 3058055

Abstract

The relation between immunohistological findings in biopsy specimens of apparently normal skin, HLA antigens, and rheumatoid factors (RF) was studied in 120 patients with rheumatoid arthritis (RA), selected for treatment with D-penicillamine. Perivascular infiltration (PVI) of more than three mononuclear cells was present in 77 (68%) of 114 patients, accompanied usually by the presence of IgM or C3, or both, in immunofluorescence studies. The number of perivascular cells was associated significantly with the titre of circulating RF. A weak relation of both perivascular cellular infiltration and RF with HLA-DR3 and DR4 did not reach statistical significance. It is concluded that the histological presence of perivascular inflammation is associated mainly with deposition of RF. It is suggested that the first is merely an epiphenomenon of the latter. PVI was not prognostic for the occurrence of the clinical syndrome of rheumatoid vasculitis. For practical purposes skin biopsies do not appear to be useful in the evaluation of individual patients with RA.

Full text

PDF
838

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAUM J., STASTNY P., ZIFF M. EFFECTS OF THE RHEUMATOID FACTOR AND ANTIGEN-ANTIBODY COMPLEXES ON THE VESSELS OF THE RAT MESENTERY. J Immunol. 1964 Dec;93:985–992. [PubMed] [Google Scholar]
  2. Calin A., Marks S. H. The case against seronegative rheumatoid arthritis. Am J Med. 1981 May;70(5):992–994. doi: 10.1016/0002-9343(81)90846-9. [DOI] [PubMed] [Google Scholar]
  3. Chalmers I. M. Ankylosing spondylitis in African Blacks. Arthritis Rheum. 1980 Dec;23(12):1366–1370. doi: 10.1002/art.1780231206. [DOI] [PubMed] [Google Scholar]
  4. Conn D. L., Schroeter A. L., McDuffie F. C. Cutaneous vessel immune deposits in rheumatoid arthritis. Arthritis Rheum. 1976 Jan-Feb;19(1):15–20. doi: 10.1002/art.1780190102. [DOI] [PubMed] [Google Scholar]
  5. Dobloug J. H., Førre O., Kåss E., Thorsby E. HLA antigens and rheumatoid arthritis. Association between HLA-DRw4 positivity and IgM rheumatoid factor production. Arthritis Rheum. 1980 Mar;23(3):309–313. doi: 10.1002/art.1780230307. [DOI] [PubMed] [Google Scholar]
  6. Emery P., Panayi G. S., Welsh K. I., Cole B. C. Rheumatoid factors and HLA-DR4 in RA. J Rheumatol. 1985 Apr;12(2):217–222. [PubMed] [Google Scholar]
  7. FeltkampVroom T. M., Stallman P. J., Aalberse R. C., Reerink-Brongers E. E. Immunofluorescence studies on renal tissue, tonsils, adenoids, nasal polyps, and skin of atopic and nonatopic patients, with special reference to IgE. Clin Immunol Immunopathol. 1975 Sep;4(3):392–404. doi: 10.1016/0090-1229(75)90008-2. [DOI] [PubMed] [Google Scholar]
  8. Floyd M., Tesar J. T. The role of IgM rheumatoid factor in experimental immune vasculitis. Clin Exp Immunol. 1979 Apr;36(1):165–174. [PMC free article] [PubMed] [Google Scholar]
  9. González T., Garcia-Montelongo R., Gantes M. Cutaneous microvasculopathy in rheumatoid arthritis. J Rheumatol. 1985 Dec;12(6):1206–1207. [PubMed] [Google Scholar]
  10. Gran J. T., Husby G., Thorsby E. HLA DR antigens in rheumatoid arthritis. Scand J Rheumatol. 1983;12(3):241–245. doi: 10.3109/03009748309098541. [DOI] [PubMed] [Google Scholar]
  11. Gran J. T., Husby G., Thorsby E. HLA antigens in palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis. J Rheumatol. 1984 Apr;11(2):136–140. [PubMed] [Google Scholar]
  12. Griffin A. J., Wooley P., Panayi G. S., Batchelor J. R. HLA DR antigens and disease expression in rheumatoid arthritis. Ann Rheum Dis. 1984 Apr;43(2):218–221. doi: 10.1136/ard.43.2.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. KULKA J. P. The vascular lesions associated with rheumatoid arthritis. Bull Rheum Dis. 1959 Dec;10:201–202. [PubMed] [Google Scholar]
  14. McGill P. E., Brougham P. A., Tulloch J. Immune deposits in the skin of patients with rheumatoid arthritis. J Rheumatol. 1984 Aug;11(4):454–456. [PubMed] [Google Scholar]
  15. Mielke H., Daniel W., Deicher H., Drommer W., Fischer M., Fritsch R., Müller-Vahl H., Sybrecht G. W. A three-year prospective study of systemic manifestation in rheumatoid arthritis. Clin Rheumatol. 1987 Sep;6 (Suppl 2):26–34. doi: 10.1007/BF02203382. [DOI] [PubMed] [Google Scholar]
  16. Moens H. J., Ament B. J., Feltkamp B. W., van der Korst J. K. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens. J Rheumatol. 1987 Dec;14(6):1115–1119. [PubMed] [Google Scholar]
  17. Nelson H. M., MacKie R. M. Studies in cutaneous immunofluorescence. II. Histological and direct immunofluorescence observations in clinically normal skin of patients with rheumatoid arthritis. J Cutan Pathol. 1981 Apr;8(2):105–110. doi: 10.1111/j.1600-0560.1981.tb00993.x. [DOI] [PubMed] [Google Scholar]
  18. Panayi G. S., Wooley P., Batchelor J. R. Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. Br Med J. 1978 Nov 11;2(6148):1326–1328. doi: 10.1136/bmj.2.6148.1326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rapoport R. J., Kozin F., Mackel S. E., Jordon R. E. Cutaneous vascular immunofluorescence in rheumatoid arthritis. Correlation with circulating immune complexes and vasculitis. Am J Med. 1980 Mar;68(3):325–331. doi: 10.1016/0002-9343(80)90100-x. [DOI] [PubMed] [Google Scholar]
  20. Rothschild B. M., Masi A. T. Pathogenesis of rheumatoid arthritis: a vascular hypothesis. Semin Arthritis Rheum. 1982 Aug;12(1):11–31. doi: 10.1016/0049-0172(82)90020-8. [DOI] [PubMed] [Google Scholar]
  21. Scott D. G., Bacon P. A., Tribe C. R. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981 Jul;60(4):288–297. [PubMed] [Google Scholar]
  22. Walton K., Dyer P. A., Grennan D. M., Haeney M., Harris R. Clinical features, autoantibodies and HLA-DR antigens in rheumatoid arthritis. J Rheumatol. 1985 Apr;12(2):223–226. [PubMed] [Google Scholar]
  23. Westedt M. L., Breedveld F. C., Schreuder G. M., D'Amaro J., Cats A., de Vries R. R. Immunogenetic heterogeneity of rheumatoid arthritis. Ann Rheum Dis. 1986 Jul;45(7):534–538. doi: 10.1136/ard.45.7.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Westedt M. L., Meijer C. J., Vermeer B. J., Cats A., de Vries E. Rheumatoid arthritis--the clinical significance of histo- and immunopathological abnormalities in normal skin. J Rheumatol. 1984 Aug;11(4):448–453. [PubMed] [Google Scholar]
  25. Westedt M. L., Vermeer B. J., Meijer C. J., Daha M. R., Baldwin W. M., 3rd, Cats A. Immunopathological abnormalities in the normal skin of patients with rheumatoid arthritis in relation to clinical and serological findings: a one year follow up study. Ann Rheum Dis. 1987 Mar;46(3):213–218. doi: 10.1136/ard.46.3.213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Young A., Jaraquemada D., Awad J., Festenstein H., Corbett M., Hay F. C., Roitt I. M. Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities. Arthritis Rheum. 1984 Jan;27(1):20–25. doi: 10.1002/art.1780270104. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES